Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-01 Sale | 2025-08-05 8:32 pm | Verona Pharma plc | VRNA | Cunningham Kenneth Director | 10,808 | $13.14 | $142,057 | 151,776 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:31 pm | Verona Pharma plc | VRNA | Deschamps Lisa Director | 9,464 | $13.14 | $124,392 | 156,856 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:30 pm | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 9,584 | $13.14 | $125,969 | 564,071 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:28 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 208,912 | $13.14 | $2,745,877 | 13,654,760 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:27 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 58,336 | $13.14 | $766,751 | 2,953,640 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:26 pm | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 1,808 | $13.14 | $23,764 | 136,072 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:25 pm | Verona Pharma plc | VRNA | Austwick Michael Director | 11,288 | $13.14 | $148,366 | 84,712 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:24 pm | Verona Pharma plc | VRNA | Brady James Aloysius Director | 824 | $13.14 | $10,830 | 95,176 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:22 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 208,912 | $13.14 | $2,745,877 | 14,565,936 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:21 pm | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 1,904 | $13.14 | $25,026 | 1,570,099 (Indirect Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:20 pm | Verona Pharma plc | VRNA | Edwards Martin Director | 10,808 | $13.14 | $142,057 | 229,992 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:18 pm | Verona Pharma plc | VRNA | SHAH MAHENDRA Director | 3,608 | $13.14 | $47,422 | 165,472 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 8:17 pm | Verona Pharma plc | VRNA | Sinha Vikas Director | 4,328 | $13.14 | $56,886 | 166,112 (Direct) | View |
| 2025-06-16 Sale | 2025-06-18 4:31 pm | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $11.53 | $922,000 | 2,599,999 (Direct) | View |
| 2025-06-11 Sale | 2025-06-13 4:31 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 400,000 | $11.4 | $4,560,360 | 12,278,992 (Direct) | View |
| 2025-06-11 Sale | 2025-06-13 4:30 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 400,000 | $11.4 | $4,560,520 | 13,190,168 (Direct) | View |
| 2025-05-27 Sale | 2025-05-29 4:16 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 400,000 | $9.3349 | $3,733,944 | 12,678,992 (Direct) | View |
| 2025-05-27 Sale | 2025-05-29 4:15 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 400,000 | $9.3364 | $3,734,579 | 13,590,168 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 4:06 pm | Verona Pharma plc | VRNA | Sinha Vikas Director | 160,000 | $9.3933 | $1,502,928 | 74,824 (Direct) | View |
| 2025-04-29 Sale(A) | 2025-05-22 4:05 pm | Verona Pharma plc | VRNA | Sinha Vikas Director | 160,000 | $8.9208 | $1,427,328 | 234,824 (Direct) | View |
| 2025-05-15 Sale | 2025-05-16 4:31 pm | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $8.57 | $685,600 | 2,679,999 (Direct) | View |
| 2025-05-14 Sale | 2025-05-16 4:30 pm | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 40,000 | $8.44 | $337,600 | 241,880 (Direct) | View |
| 2025-05-06 Sale | 2025-05-08 4:30 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 114,984 | $8.8216 | $1,014,343 | 2,546,472 (Direct) | View |
| 2025-05-01 Sale | 2025-05-05 4:32 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 49,200 | $8.9502 | $440,350 | 2,911,456 (Direct) | View |
| 2025-05-01 Sale | 2025-05-05 4:31 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 587,008 | $9.0484 | $5,311,479 | 14,078,992 (Direct) | View |
| 2025-05-01 Sale | 2025-05-05 4:30 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 587,008 | $9.0481 | $5,311,279 | 14,990,168 (Direct) | View |
| 2025-04-29 Sale | 2025-05-01 8:59 pm | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 26,072 | $8.98 | $234,127 | 780,169 (Direct) | View |
| 2025-04-29 Sale | 2025-05-01 8:58 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 90,360 | $8.98 | $811,433 | 16,697,664 (Direct) | View |
| 2025-04-29 Sale | 2025-05-01 8:56 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 34,384 | $8.98 | $308,768 | 3,380,832 (Direct) | View |
| 2025-04-29 Sale | 2025-05-01 8:55 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 90,360 | $8.98 | $811,433 | 15,786,488 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-29 Gift | 2025-09-03 4:32 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 1,200,000 | $0 | 12,176,144 (Direct) | View |
| 2025-08-29 Gift | 2025-09-03 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 189,600 | $0 | 2,417,872 (Direct) | View |
| 2025-08-29 Gift | 2025-09-03 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 1,200,000 | $0 | 11,264,968 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:32 pm | N/A N/A | Verona Pharma plc | VRNA | Cunningham Kenneth Director | 24,000 | $0 | 151,776 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:31 pm | N/A N/A | Verona Pharma plc | VRNA | Deschamps Lisa Director | 24,000 | $0 | 156,856 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:30 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 20,888 | $0 | 564,071 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:28 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 511,392 | $0 | 13,654,760 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:27 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 141,776 | $0 | 2,953,640 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:26 pm | N/A N/A | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 24,000 | $0 | 136,072 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:25 pm | N/A N/A | Verona Pharma plc | VRNA | Austwick Michael Director | 24,000 | $0 | 84,712 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:24 pm | N/A N/A | Verona Pharma plc | VRNA | Brady James Aloysius Director | 24,000 | $0 | 95,176 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:22 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 511,392 | $0 | 14,565,936 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:21 pm | N/A N/A | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 24,000 | $0 | 1,570,099 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:20 pm | N/A N/A | Verona Pharma plc | VRNA | Edwards Martin Director | 24,000 | $0 | 229,992 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:18 pm | N/A N/A | Verona Pharma plc | VRNA | SHAH MAHENDRA Director | 24,000 | $0 | 165,472 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:17 pm | N/A N/A | Verona Pharma plc | VRNA | Sinha Vikas Director | 24,000 | $0 | 166,112 (Direct) | View |
| 2025-08-01 Exercise | 2025-08-05 8:16 pm | N/A N/A | Verona Pharma plc | VRNA | Ullman Anders Director | 24,000 | $0 | 430,856 (Direct) | View |
| 2025-07-08 Tax Withholding | 2025-07-09 6:41 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 90,320 | $11.44 | 13,538,768 (Direct) | View |
| 2025-07-07 Exercise | 2025-07-09 6:41 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 229,512 | $0 | 13,538,768 (Direct) | View |
| 2025-07-07 Option Award | 2025-07-09 6:41 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 675,048 | $0 | 13,538,768 (Direct) | View |
| 2025-07-08 Tax Withholding | 2025-07-09 6:39 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 37,616 | $11.44 | 3,015,096 (Direct) | View |
| 2025-07-07 Exercise | 2025-07-09 6:39 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 86,064 | $0 | 3,015,096 (Direct) | View |
| 2025-07-07 Option Award | 2025-07-09 6:39 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 253,120 | $0 | 3,015,096 (Direct) | View |
| 2025-07-08 Tax Withholding | 2025-07-09 6:38 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 39,464 | $11.44 | 826,775 (Direct) | View |
| 2025-07-07 Exercise | 2025-07-09 6:38 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 86,064 | $0 | 826,775 (Direct) | View |
| 2025-07-07 Option Award | 2025-07-09 6:38 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 253,120 | $0 | 826,775 (Direct) | View |
| 2025-07-08 Tax Withholding | 2025-07-09 6:37 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 90,320 | $11.44 | 14,449,944 (Direct) | View |
| 2025-07-07 Exercise | 2025-07-09 6:37 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 229,512 | $0 | 14,449,944 (Direct) | View |
| 2025-07-07 Option Award | 2025-07-09 6:37 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 675,048 | $0 | 14,449,944 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-18 4:31 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $2.0113 | 2,599,999 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-18 4:31 pm | N/A 2034-03-31 | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $0 | 2,599,999 (Direct) | View |
| 2025-05-15 Exercise(A) | 2025-06-18 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $2.0113 | 2,759,999 (Direct) | View |
| 2025-05-15 Exercise(A) | 2025-06-18 4:30 pm | N/A 2034-03-31 | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $0 | 2,759,999 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-22 4:06 pm | N/A 2032-04-27 | Verona Pharma plc | VRNA | Sinha Vikas Director | 160,000 | $0 | 74,824 (Direct) | View |
| 2025-05-20 Exercise | 2025-05-22 4:06 pm | N/A N/A | Verona Pharma plc | VRNA | Sinha Vikas Director | 160,000 | $0.5038 | 74,824 (Direct) | View |
| 2025-04-29 Exercise(A) | 2025-05-22 4:05 pm | N/A 2027-04-26 | Verona Pharma plc | VRNA | Sinha Vikas Director | 160,000 | $0 | 234,824 (Direct) | View |
| 2025-04-29 Exercise(A) | 2025-05-22 4:05 pm | N/A N/A | Verona Pharma plc | VRNA | Sinha Vikas Director | 120,384 | $1.7 | 234,824 (Direct) | View |
| 2025-04-29 Exercise(A) | 2025-05-22 4:05 pm | N/A N/A | Verona Pharma plc | VRNA | Sinha Vikas Director | 39,616 | $0.5038 | 234,824 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-16 4:31 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $2.113 | 2,679,999 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-16 4:31 pm | N/A 2034-03-31 | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 80,000 | $0 | 2,679,999 (Direct) | View |
| 2025-05-14 Exercise | 2025-05-16 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 40,000 | $1.9338 | 241,880 (Direct) | View |
| 2025-05-14 Exercise | 2025-05-16 4:30 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 40,000 | $0 | 241,880 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:32 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 50,000 | $0 | 2,911,456 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:31 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 200,000 | $0 | 14,078,992 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 140,000 | $1.9338 | 1,476,003 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:30 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 140,000 | $0 | 1,476,003 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 4:30 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 200,000 | $0 | 14,990,168 (Direct) | View |
| 2025-03-19 Gift | 2025-05-01 8:59 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 1 | $0 | 780,169 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:59 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 86,064 | $0 | 780,169 (Direct) | View |
| 2025-04-29 Option Award | 2025-05-01 8:59 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 253,120 | $0 | 780,169 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:58 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 229,512 | $0 | 16,697,664 (Direct) | View |
| 2024-08-07 Option Award | 2025-05-01 8:58 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 1,875,000 | $0 | 16,697,664 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:56 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 86,064 | $0 | 3,380,832 (Direct) | View |
| 2024-08-07 Option Award | 2025-05-01 8:56 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 553,120 | $0 | 3,380,832 (Direct) | View |
| 2025-04-29 Exercise | 2025-05-01 8:55 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 229,512 | $0 | 15,786,488 (Direct) | View |
| 2024-08-07 Option Award | 2025-05-01 8:55 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 1,875,000 | $0 | 15,786,488 (Direct) | View |